Choline Fenofibrate Patent Expiration
Choline Fenofibrate was first introduced by Abbvie Inc
Choline Fenofibrate Patents
Given below is the list of patents protecting Choline Fenofibrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Trilipix | US7259186 | Salts of fenofibric acid and pharmaceutical formulations thereof | Jan 07, 2025 | Abbvie |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Choline Fenofibrate's patents.
Latest Legal Activities on Choline Fenofibrate's Patents
Given below is the list recent legal activities going on the following patents of Choline Fenofibrate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Jan, 2019 | US7259186 |
| Recordation of Patent Grant Mailed Critical | 21 Aug, 2007 | US7259186 |
| Patent Issue Date Used in PTA Calculation Critical | 21 Aug, 2007 | US7259186 |
| Issue Notification Mailed Critical | 01 Aug, 2007 | US7259186 |
| Application Is Considered Ready for Issue Critical | 21 Jun, 2007 | US7259186 |
| Dispatch to FDC | 21 Jun, 2007 | US7259186 |
| Issue Fee Payment Verified Critical | 19 Jun, 2007 | US7259186 |
| Issue Fee Payment Received Critical | 19 Jun, 2007 | US7259186 |
| Electronic Review Critical | 13 Jun, 2007 | US7259186 |
| Email Notification Critical | 12 Jun, 2007 | US7259186 |
Choline Fenofibrate's Family Patents
Explore Our Curated Drug Screens
Choline Fenofibrate Generic API Manufacturers
Several generic applications have been filed for Choline Fenofibrate. The first generic version for Choline Fenofibrate was by Norvium Bioscience Llc and was approved on Mar 25, 2013. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Feb 8, 2024.
Given below is the list of companies who have filed for Choline Fenofibrate generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Oct 7, 2015 |
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Oct 7, 2015 |
Manufacturing Plant Locations New
Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
2. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | May 12, 2017 |
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | May 12, 2017 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
3. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Jul 25, 2019 |
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Jul 25, 2019 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
4. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Dec 4, 2013 |
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Dec 4, 2013 |
5. ENDO OPERATIONS
Endo Operations Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Discontinued | ORAL | N/A | Jul 18, 2013 |
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Discontinued | ORAL | N/A | Jul 18, 2013 |
6. IMPAX LABS INC
Impax Laboratories Inc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Sep 7, 2016 |
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Sep 7, 2016 |
7. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Discontinued | ORAL | N/A | Feb 8, 2024 |
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Discontinued | ORAL | N/A | Feb 8, 2024 |
8. MICRO LABS
Micro Labs Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Jun 16, 2020 |
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Jun 16, 2020 |
Manufacturing Plant Locations New
Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
9. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Discontinued | ORAL | N/A | Mar 25, 2013 |
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Discontinued | ORAL | N/A | Mar 25, 2013 |
10. RISING
Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Jul 18, 2019 |
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Jul 18, 2019 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
11. TWI PHARMS
Twi Pharmaceuticals Inc has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Twi Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Discontinued | ORAL | N/A | Jul 5, 2019 |
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Discontinued | ORAL | N/A | Jul 5, 2019 |
12. YICHANG HUMANWELL
Yichang Humanwell Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Choline Fenofibrate. All of these versions come by the name FENOFIBRIC ACID. Given below are the details of the strengths of this generic introduced by Yichang Humanwell.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 45MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Dec 23, 2020 |
| EQ 135MG FENOFIBRIC ACID | capsule, delayed release | Prescription | ORAL | AB | Dec 23, 2020 |
Manufacturing Plant Locations New
Yichang Humanwell's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yichang Humanwell as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||